Holen Sie sich die Stockscreener-App
382.19
1.51%
5.69
Handel nachbörslich:
377.42
-4.77
-1.25%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$376.50
Offen:
$381.53
24-Stunden-Volumen:
2.70M
Relative Volume:
1.67
Marktkapitalisierung:
$84.78B
Einnahmen:
$76.39B
Nettoeinkommen (Verlust:
$7.81B
KGV:
13.14
EPS:
29.0772
Netto-Cashflow:
$7.93B
1W Leistung:
+2.97%
1M Leistung:
-1.44%
6M Leistung:
-18.83%
1J Leistung:
+11.92%
1-Tages-Spanne:
$376.48
$399.00
1-Wochen-Bereich:
$366.51
$399.00
52-Wochen-Spanne:
$330.00
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
382.19 | 84.78B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
233.20 | 20.09B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
235.44 | 15.11B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.59 | 13.21B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
112.89 | 11.20B | 6.07B | 793.80M | 464.40M | 5.9914 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
2,761 Shares in HCA Healthcare, Inc. $HCA Purchased by Caxton Associates LLP - MarketBeat
Bank of Nova Scotia Buys 12,749 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare Reported Q2 Earnings. Here’s What the Guide Cut Really Means. - TIKR.com
Healthcare of Ontario Pension Plan Trust Fund Has $180.51 Million Stock Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
Lido Advisors LLC Has $5.62 Million Stock Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
Cumberland Partners Ltd Lowers Stake in HCA Healthcare, Inc. $HCA - MarketBeat
Epoch Investment Partners Inc. Cuts Stock Position in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare stock edges higher as strong Q1 2026 earnings and guidance underpin valuation - AD HOC NEWS
HCA Healthcare, Inc. Revenue Breakdown – NYSE:HCA - TradingView
HCA Healthcare (HCA) Reports Q2 2026 Earnings Amid Payer Mix Cha - GuruFocus
'Potential non-compliance' noted in 2025 Mission purchase agreement - WLOS
HCA Healthcare (HCA) Reports Q2 Earnings, Revises 2026 Guidance - GuruFocus
HCA Q2 FY2026 earnings call - finance.biggo.com
HCA Healthcare Inc (HCA) Q2 2026 Earnings Call Highlights: Navigating Growth Amidst Challenges - Yahoo! Finance Canada
HCA Healthcare Inc Revenue Breakdown – MUN:2BH - TradingView
HCA Healthcare, Inc. (HCA) Stock Forecasts - Yahoo Finance
HCA Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm - NewMediaWire
HCA: EPS up 11% in Q2, but exchange attrition drove uninsured volumes and pressured EBITDA - TradingView
HCA Healthcare, Mission monitor reports potential non-compliance for 3rd straight year - The Asheville Citizen Times
HCA Monitoring Report for 2025, Two Areas of Potential Non-Compliance Noted - WKYK
HCA Healthcare Q2 Earnings Call Highlights - MarketBeat
HCA Healthcare (NYSE:HCA) Posts Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
HCA Q2 Earnings Beat on Strong Admissions, 2026 Outlook Revised - TradingView
HCA: EPS up 11% as payer mix shift drives uninsured growth; guidance revised amid Medicaid offsets - TradingView
HCA Healthcare Surpasses Q2 Estimates With Strong Admissions Growth - Benzinga
Earnings call transcript: HCA beats Q2 2026 estimates as shares rise 3.6% - Investing.com
HCA Healthcare, Inc (HCA) Q2 2026 Earnings Call Transcript - AlphaStreet
HCA Healthcare Sees 2026 Adjusted Ebitda $15.4B-$16.1B >HCA - Moomoo
HCA Healthcare (HCA) Q2 2026 earnings summary - Quartr
Tranche Update on HCA Healthcare, Inc.'s Equity Buyback Plan announced on January 27, 2026. - marketscreener.com
HCA Healthcare (NYSE:HCA) Stock Price Up 4.2% Following Strong Earnings - MarketBeat
HCA Healthcare, Inc. (HCA) Q2 FY2026 earnings call transcript - Yahoo Finance
HCA Healthcare 2Q Profit Boosted by Florida Medicaid Program - Moomoo
HCA, Q2 Earnings Beat Expectations but Full-Year Guidance Lowered - GuruFocus
HCA Healthcare Inc reports results for the quarter ended June 30Earnings Summary - TradingView
HCA (HCA) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance UK
HCA, Strong Q2 Earnings Offset by Downgraded Full-Year Guidance - GuruFocus
HCA Healthcare (HCA) Q2 Earnings Surpass Estimates - Yahoo Finance
Is HCA Healthcare Inc (HCA) Undervalued Despite Q2 EPS Beat? GF Score: 91/100 - GuruFocus
HCA Reports Strong Q2 Revenue Despite Payer Mix Challenges - GuruFocus
HCA Healthcare beats estimates but cuts guidance By Investing.com - Investing.com South Africa
HCA Healthcare’s (NYSE:HCA) Q2 CY2026 Sales Top Estimates - The Globe and Mail
HCA Healthcare beats estimates but cuts guidance - Investing.com
HCA Healthcare Q2 revenue rises on Medicaid programs; narrows outlook - TradingView
(HCA) HCA Healthcare Expects 2026 Revenue Range $77.00B to $79.50B, vs. FactSet Est of $78.47B - marketscreener.com
HCA: Revenue up 8.7% in Q2 2026, but payer mix shifts and lower surgeries pressured margins - TradingView
HCA: Q2 Earnings Snapshot - 10TV
Earnings Flash (HCA) HCA Healthcare, Inc. Reports Q2 Revenue $20.23B, vs. FactSet Est of $19.77B - marketscreener.com
Earnings Flash (HCA) HCA Healthcare, Inc. Posts Q2 Adjusted EPS $7.59 per Share, vs. FactSet Est of $7.56 - marketscreener.com
HCA Healthcare Reports Second Quarter 2026 Results - The Joplin Globe
Press Release: HCA Healthcare Reports Second Quarter 2026 Results - Moomoo
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Hca Healthcare Inc-Aktie (HCA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| McAlevey Michael R | EVP & Chief Legal & Admin Off. |
Feb 18 '26 |
Sale |
533.37 |
1,694 |
903,537 |
8,853 |
17.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):